ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03515369
Recruitment Status : Not yet recruiting
First Posted : May 3, 2018
Last Update Posted : May 3, 2018
Sponsor:
Collaborators:
Shanghai Zhongshan Hospital
Fujian Mengchao Hepatobiliary Hospital
Sun Yat-sen University
First Affiliated Hospital, Sun Yat-Sen University
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Second Military Medical University
Xiamen Traditional Chinese Medicine Co., Ltd.
Information provided by (Responsible Party):
Shen Feng, Eastern Hepatobiliary Surgery Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : January 2022
  Estimated Study Completion Date : June 2022